RegenxBio Inc. (NASDAQ:RGNX) raised $175.5 million through the sale of 2.7 million shares at $65 in a follow-on underwritten by Morgan Stanley, BofA Merrill Lynch, Barclays and Raymond James.
Venture investor Krishna Yeshwant uses a healthy amount of skepticism when vetting potential companies to invest in. His favorite time to invest is when one of his partners at the fund is excited about a particular company, even if nobody else is.
To better understand one of the most heated U.S. policy debates, we created a tournament to judge which of these nations has the best health system: Canada, Britain, Singapore, Germany, Switzerland, France, Australia and the U.S.
In the first such clinical trial in the United States, physician-scientists with the University of Maryland School of Medicine (UMSOM) are investigating the use of MRI-guided focused ultrasound to open the blood-brain barrier. The trial will be conducted with patients undergoing brain cancer surgery at the University of Maryland Medical Center (UMMC).
Recently, ClearMask received $25,000 in grant funding from the National Science Foundation (NSF) to support ClearMask’s commercialization efforts. The funding is part of the NSF’s National Innovation Corps (I-Corps) program that helps scientists and engineers move their technologies toward commercialization.
In last week’s Amplified column, I discussed how the traditional wisdom that small business pursues disruptive innovation and big business pursues sustaining innovation may no longer hold. This is especially likely in industries consisting of only a few large players that both have the resources to engage in disruptive innovation themselves and to raise the costs of entry to would-be competitors.
Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an agreement to acquire PaxVax, a company focused on specialty vaccines that protect against existing and emerging infectious diseases, for an all-cash consideration of $270 million. PaxVax is majority owned by an affiliate of Cerberus Capital Management, L.P.
Maryland’s health tech startup ecosystem is at it again. Silver Spring-based startup which is named as Aziyo Biologics Inc. has raised an amount of $10 million from seven leading investors in a funding round which has been disclosed yesterday night in SEC filings.
After a week of persistent rain throughout Maryland, it was blue skies and a perfect 85-degree summer afternoon that marked an important day for Paragon Bioservices and their 250+ employees. Dozens of those employees stepped off a charter bus from Baltimore to see the brand new 151,000 sq/ft GMP biomanufacturing facility near BWI for the first time. The wide-open parking lots and 200 yards between the nearest building presented a much different landscape than they were used to at their current UM BioPark location in the city. An afternoon picnic and site tour was organized as a celebration for their employees, who got to enjoy some delicious ole’ fashioned BBQ, music and games outside before a short welcome ceremony.
We want to offer you the best possible experience when using the OrganoPlate® for your experiments. This page contains training videos and protocols to get you started. For optimal user experience, we recommend you to follow these 5 steps before your first experiment: